Advanced search
Publication Cover
Research and Reports in Neonatology Volume 5, 2015 - Issue
Submit an article Journal homepage
58
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Response to bronchodilators in very preterm infants with evolving bronchopulmonary dysplasia

Daniel K MorrowDepartment of Pediatrics, Oregon Health and Science University, Portland, OR, USACorrespondence[email protected]
,
Diane SchillingDepartment of Pediatrics, Oregon Health and Science University, Portland, OR, USA
&
Cindy T McEvoyDepartment of Pediatrics, Oregon Health and Science University, Portland, OR, USA
Pages 113-117 | Published online: 02 Dec 2015

References

  • Bhandari A, McGrath-Morrow S. Long-term pulmonary outcomes of patients with bronchopulmonary dysplasia. Semin Perinatol. 2013;37:132–137.
  • Gien J, Kinsella JP. Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr. 2011;23:305–313.
  • Kobaly K, Schluchter M, Minich N, et al. Outcomes of extremely low birth weight (<1 kg) and extremely low gestational age (<28 weeks) infants with bronchopulmonary dysplasia: effects of practice changes in 2000 to 2003. Pediatrics. 2008;121:73–81.
  • Jobe AH. Antenatal factors and the development of bronchopulmonary dysplasia. Semin Neonatol. 2003;8:9–17.
  • Somaschini M, Castiglioni E, Volonteri C, Cursi M, Ferrari M, Carrera P. Genetic predisposing factors bronchopulmonary dysplasia: preliminary data from a multicentre study. J Matren Fetal Neonatal Med. 2012;Suppl 4:127–130.
  • Wang H, St Julien KR, Stevenson DK, et al. A genome-wide association study (GWAS) for bronchopulmonary dysplasia. Pediatrics. 2013;132:290–297.
  • Li J, Yu KH, Oehlert J, et al. Exome sequencing of neonatal blood spots and the identification of genes implicated in bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2015;192:589–596.
  • Ng G, da Silva O, Ohlsson A. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2012;6:CD003214.
  • Denjean A, Paris-Llado J, Zupan V, et al. Inhaled salbutamol and beclomethasone for preventing broncho-pulmonary dysplasia: a randomised double-blind study. Eur J Pediatr. 1998;157:926–931.
  • Hibbs AM, Walsh MC, Martin RJ, et al. One-year respiratory outcomes of preterm infants enrolled in the nitric oxide (to prevent) Chronic Lung Disease trial. J Pediatr. 2008;153:525–529.
  • Fawke J, Lum S, Kirkby J, et al. Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study. Am J Respir Crit Care Med. 2010;182:237–245.
  • Ronkainen E, Dunder T, Peltoniemi O, Kaukola T, Marttila R, Hallman M. New BPD predicts lung function at school age: follow-up study and meta-analysis. Pediatr Pulmonol. 2015;50:1090–1908.
  • Vom Hove M, Prenzel F, Uhlig HH, Robel-Tillig E. Pulmonary outcome in former preterm, very low birth weight children with bronchopulmonary dysplasia: a case-control follow-up at school age. J Pediatr. 2014;164:40–45.
  • Kotecha SJ, Edwards MO, Watkins WJ, Lowe J, Henderson AJ, Kotecha S. Effect of bronchodilators on forced expiratory volume in 1 s in preterm-born participants aged 5 and over: a systematic review. Neonatology. 2015;107:231–240.
  • National Asthma E, Prevention P. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics – 2002. J Allergy Clin Immunol. 2002;110:S141–S219.
  • Gappa M, Colin AA, Goetz I, Stocks J. Passive respiratory mechanics: the occlusion techniques. Eur Respir J. 2001;17:141–148.
  • McEvoy C, Schilling D, Spitale P, Peters D, O’Malley J, Durand M. Decreased respiratory compliance in infants less than or equal to 32 weeks’ gestation, delivered more than 7 days after antenatal steroid therapy. Pediatrics. 2008;121:e1032–e1038.
  • Morris MG, Gustafsson P, Tepper R, Gappa M, Stocks J. The bias flow nitrogen washout technique for measuring the functional residual capacity in infants. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. Eur Respir J. 2001;17:529–536.
  • McEvoy C, Schilling D, Peters D, et al. Respiratory compliance in preterm infants after a single rescue course of antenatal steroids: a randomized controlled trial. Am J Obstet Gynecol. 2010;202:544. e1–e9.
  • Laitinen LA, Laitinen A, Haahtela T. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J Allergy Clin Immunol. 1992;90:32–42.
  • Bhandari V. Postnatal inflammation in the pathogenesis of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol. 2014;100:189–201.
  • Ericson JE, Laughon MM. Chorioamnionitis: implications for the neonate. Clin Perinatol. 2015;42:155–165.
  • Ehrenkranz RA, Walsh MC, Vohr BR, et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics. 2005;116:1353–1360.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.